Investigational Site Number : 6160003

Poznan, Greater Poland Voivodeship 61-866

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer Metastatic

Studies at this site

• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early